“The hemophilic patient also suffers from hemarthrosis (the accumulation of blood in the joint after bleeding, ed) silent, due to the phenomenon of synovial hypertrophy, in which the regenerated tissue is very vascularized, and therefore a traumatic stimulus is not necessary to cause hemorrhages in the joints. Joint well-being is linked to a sufficient level of factor VIII (protein whose activity is reduced or eliminated by haemophilia, ed) at any time of the day, and it is essential that the patient adheres to the therapy, which can best adapt it to his lifestyle”. Così Antonella Coluccia, hematologist at the Center for haemophilia and rare coagulopathies at the hospital of Scorrano (Le), he argued the importance of follow-up in haemophilia prophylaxis during the seventh stage of ‘Articoliamo’, a campaign supported by Sobi with the patronage of FedEmo, created to promote joint well-being in people with haemophilia and landed today in Bari.
“The doctor must not only be the one who prescribes – explained the expert – but must monitor the joint status with ultrasound and check for haemarthroses not detected by the patient and decide whether to increase the dose or frequency of drug administration. It is a way to tailor the therapy to the patient, also thanks to the adoption of musculoskeletal ultrasound as a diagnostic aid “.